Health Canada not doing enough to discipline big pharma on false advertising: critics
Department responses indicate the government’s hesitation to enforce regulations that prohibit promoting prescription medication.
Compliance letters seem to be Health Canada’s drug of choice when it comes to reprimanding pharmaceutical companies that advertise false claims about drugs, but critics and academics say the approach isn’t enough.
SPONSORED CONTENT
Get Today’s Headlines Newsletter
Your quick scan of the news you need each weekday to be the smartest person in the room.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
